Barclays’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $40.3M | Buy |
933,512
+544,674
| +140% | +$23.5M | 0.01% | 594 |
|
2025
Q1 | $13.4M | Sell |
388,838
-58,672
| -13% | -$2.03M | ﹤0.01% | 874 |
|
2024
Q4 | $12.3M | Sell |
447,510
-97,498
| -18% | -$2.68M | ﹤0.01% | 1005 |
|
2024
Q3 | $13.9M | Buy |
545,008
+131,743
| +32% | +$3.35M | ﹤0.01% | 874 |
|
2024
Q2 | $10.5M | Buy |
413,265
+8,097
| +2% | +$205K | ﹤0.01% | 887 |
|
2024
Q1 | $12.5M | Sell |
405,168
-336,870
| -45% | -$10.4M | ﹤0.01% | 911 |
|
2023
Q4 | $30M | Buy |
742,038
+260,598
| +54% | +$10.5M | 0.01% | 640 |
|
2023
Q3 | $12.7M | Sell |
481,440
-107,724
| -18% | -$2.84M | 0.01% | 796 |
|
2023
Q2 | $10.1M | Sell |
589,164
-81,715
| -12% | -$1.41M | 0.01% | 903 |
|
2023
Q1 | $11.1M | Sell |
670,879
-531,006
| -44% | -$8.8M | 0.01% | 773 |
|
2022
Q4 | $9.16M | Buy |
1,201,885
+875,468
| +268% | +$6.67M | ﹤0.01% | 859 |
|
2022
Q3 | $3.24M | Buy |
326,417
+296,979
| +1,009% | +$2.95M | ﹤0.01% | 1344 |
|
2022
Q2 | $268K | Sell |
29,438
-13,148
| -31% | -$120K | ﹤0.01% | 2977 |
|
2022
Q1 | $432K | Sell |
42,586
-151,488
| -78% | -$1.54M | ﹤0.01% | 2896 |
|
2021
Q4 | $3.24M | Buy |
194,074
+104,508
| +117% | +$1.74M | ﹤0.01% | 1510 |
|
2021
Q3 | $4.2M | Buy |
89,566
+26,546
| +42% | +$1.24M | ﹤0.01% | 1344 |
|
2021
Q2 | $3.84M | Sell |
63,020
-37,199
| -37% | -$2.27M | ﹤0.01% | 1343 |
|
2021
Q1 | $6.17M | Buy |
100,219
+63,771
| +175% | +$3.93M | ﹤0.01% | 1052 |
|
2020
Q4 | $2.59M | Buy |
36,448
+3,076
| +9% | +$219K | ﹤0.01% | 1424 |
|
2020
Q3 | $1.25M | Sell |
33,372
-12,116
| -27% | -$455K | ﹤0.01% | 1784 |
|
2020
Q2 | $1.48M | Buy |
45,488
+16,124
| +55% | +$526K | ﹤0.01% | 1671 |
|
2020
Q1 | $851K | Buy |
29,364
+3,230
| +12% | +$93.6K | ﹤0.01% | 1830 |
|
2019
Q4 | $916K | Buy |
26,134
+12,431
| +91% | +$436K | ﹤0.01% | 2350 |
|
2019
Q3 | $294K | Sell |
13,703
-3,631
| -21% | -$77.9K | ﹤0.01% | 2882 |
|
2019
Q2 | $467K | Buy |
+17,334
| New | +$467K | ﹤0.01% | 2749 |
|